Resmed 4Q16 Result

RMD.ASX 4Q16 results come out tomorrow. Will be interesting to see the numbers, we hold this name in the model portfolio and we’re looking for ongoing strength through to our $9.00 exit target.

Looking for NPAT of around $370 – 380million and 29 cents of dividends. Watching the sales growth rate data on the US flow generators.

You're not a member!  Trial today!


Author: Leon Hinde

Leon has been working in the financial services industry for 18 years in management and advisory roles. Leon has extensive experience in general advice and dealings involving securities and derivative financial products.

PS 146 Securities & Derivatives, ADA 1 & 2 accreditation, Responsible Manager Certificate. Leon is authorised to provide financial product advice and deal with respect to the following financial products:

· Deposit Products
· Securities
· Derivatives
· Interest in managed investment schemes; and
· Government debentures, bonds and stocks